Stock Earnings

Question 1

Novozymes A/S'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Novozymes A/S'in toplam varlıkları $15,195 olup, net profit $305'dir.

Question 2

NVZMY'ün temel finansal oranları nelerdir?

Accepted Answer

Novozymes A/S'in cari oranı 3.78, net kâr marjı 7.95, hisse başına satış $8.33'dir.

Question 3

Novozymes A/S'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Novozymes A/S largest revenue segment is Bioenergy, at a revenue of 596,326,170 in the most earnings release.For geography, Europe, Middle East & Africa is the primary market for Novozymes A/S, at a revenue of 1,408,400,000.

Question 4

Novozymes A/S kârlı mı?

Accepted Answer

yes, son mali tablolara göre Novozymes A/S'in net profit $305'dir.

Question 5

Novozymes A/S'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Novozymes A/S'in yükümlülüğü 4,019'dir.

Question 6

Novozymes A/S'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Novozymes A/S'in toplam tedavüldeki hisse sayısı 466.13'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	4,097	3,833	2,398	2,351	2,005	14,012
Revenue Growth (YoY)	35%	60%	2%	17%	-86%	-3%
Cost of Revenue	1,916	2,024	1,095	1,068	846	6,159
Gross Profit	2,181	1,809	1,302	1,283	1,158	7,853
Selling, General & Admin	838	659	416	400	345	2,163
Research & Development	435	333	232	221	222	1,622
Operating Expenses	1,250	1,150	704	686	631	4,243
Other Non Operating Income (Expenses)	--	-11	11	14	-1	-31
Pretax Income	746	417	523	610	526	3,521
Income Tax Expense	181	111	116	116	104	695
Net Income	564	305	405	492	421	2,825
Net Income Growth	99%	-25%	-18%	17%	-85%	-10%
Shares Outstanding (Diluted)	467.7	459.6	277.87	278.73	280.22	282.02
Shares Change (YoY)	2%	65%	0%	-1%	-1%	-2%
EPS (Diluted)	1.21	0.66	1.45	1.76	1.5	10.01
EPS Growth	96%	-54%	-17%	17%	-85%	-9%
Free Cash Flow	568	660	280	149	378	3,415
Free Cash Flow Per Share	1.21	1.43	1	0.53	1.34	12.1
Gross Margin	53.23%	47.19%	54.29%	54.57%	57.75%	56.04%
Operating Margin	22.72%	17.19%	24.93%	25.39%	26.23%	25.76%
Profit Margin	13.76%	7.95%	16.88%	20.92%	20.99%	20.16%
Free Cash Flow Margin	13.86%	17.21%	11.67%	6.33%	18.85%	24.37%
EBITDA	--	1,256	784	795	715	4,876
EBITDA Margin	--	32.76%	32.69%	33.81%	35.66%	34.79%
D&A For EBITDA	--	597	186	198	189	1,266
EBIT	931	659	598	597	526	3,610
EBIT Margin	22.72%	17.19%	24.93%	25.39%	26.23%	25.76%
Effective Tax Rate	24.26%	26.61%	22.17%	19.01%	19.77%	19.73%

Novozymes A/S (NVZMY) Price

NVZMY Stock Price Chart

NVZMY Income

Follow-Up Questions